-
Pfizer to Supply UNICEF up to 4 Million Treatment Courses of Novel COVID-19 Oral Treatment for Low- and Middle-Income Countries
Pfizer Inc. announced today an agreement with UNICEF to supply up to 4 million treatment courses of its COVID-19 oral treatment.
- Categories
- Coronavirus, Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
Analysis: How Drug Companies Are Sidestepping the WHO’s Technology Transfer Hub in Africa
Once the platform has been fully developed and tested in Cape Town, it will facilitate technology transfer to at least 12 low- and middle-income countries.
- Categories
- Coronavirus, Health Care, Technology
- Region
- Sub-Saharan Africa
-
WHO Tech-Transfer Hub Uses Moderna Data to Make mRNA Covid Vaccine in South Africa
Afrigen is part of the mRNA technology-transfer hub, an initiative set up by the World Health Organization (WHO) last year to develop the vaccine manufacturing capacity in low- and middle-income countries.
- Categories
- Coronavirus, Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
Analysis: COVID-19 Pushing Over 500 Million People Into Extreme Poverty: UN
The pandemic is likely to halt two decades of global progress toward universal health coverage, triggering declining immunizations and increased tuberculosis and malaria deaths, the global health body said.
- Categories
- Coronavirus, Health Care
- Region
- Global
-
Report: COVID-19 Brings 10 Challenges That Hinders Africa’s Path to Recovery
Africa faces 10 key governance challenges it must resolve in order for it to fully recover from the Covid-19 outbreak, according to this report by the Mo Ibrahim Foundation.
- Categories
- Coronavirus, Health Care
- Region
- Sub-Saharan Africa
-
Cooling, Cold Chain Advances Energy Efficiency for Food, Vaccines in Africa
The Africa Centre of Excellence for Sustainable Cooling and Cold Chain (ACES) is about to enhance its reach through a network of Specialised Outreach and Knowledge Establishments (SPOKEs).
- Categories
- Energy
- Region
- Sub-Saharan Africa
-
Aspen Pharmacare, Pursuing J&J Vaccine License, Aims to Shore up Local Capacity and Quash Shot Inequality in Africa
Aspen already has a deal to package J&J's shot at its facility in South Africa. Under the terms of the potential licensing pact, Aspen would be in charge of finishing vaccine doses as well as marketing the shot on the continent. building local vaccine manufacturing capacity on the continent.
- Categories
- Coronavirus, Health Care
- Region
- Sub-Saharan Africa
- Tags
- human rights, vaccines
-
Oravax To Develop Israeli Oral COVID-19 Vaccine in Mexico
Israel’s Oravax Medical, a subsidiary of Oramed Pharmaceuticals Inc. announced this month that it has partnered with Genomma Lab Internacional, in a 50/50 joint venture to develop and commercialize Oravax’s oral COVID-19 vaccine candidate in Mexico.
- Categories
- Coronavirus
- Region
- Latin America